机译:干扰素诱导解旋酶(IFIH1)基因多态性与从自身免疫到1型糖尿病的不同进展相关。
Christiane Winkler,1 Claudia Lauber,1 Kerstin Adler,2 Harald Grallert,3 Thomas Illig,3 Anette-Gabriele Ziegler,1,2,4 and Ezio Bonifacio5From the 1 Forscher gruppe Diabetes e.V. aï Heimholte Center Munich, Neuherberg. Germany, the 3Forschergruppp Diabetes, Munich University of Technology, Munich, Germany, the ''Institute of Epidemiology, Helmhoitz Center Munich. Neuherbei'g, Germany, the 'institute of Diabetes Research, HeImholtz Center Munich, Neuherberg, Germany, and the "Center for Regenerative Therapies, Dresden University of Technology, Dresden, Germany.Corresponding author: Ezio Bonifacio, ezio. bonifacio@crt-dresden.de.Received 9 September IiOlO and accepted 18 November 2010.DOI: 10.2337/dblO-1269A. -G.Z. and E.B, share senior authorship.© 201] by UIP American Diabetes Association. Readers may use (his article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,;
机译:干扰素诱导解旋酶(IFIH1)基因多态性与从自身免疫到1型糖尿病的不同进展相关。
机译:干扰素诱导的解旋酶IFIH1 Ala946Thr多态性与高发病率芬兰人群和中等发病率匈牙利人群中的1型糖尿病相关
机译:干扰素诱导的螺旋酶(IFIH1 IFIH1 IFIH1)之间的关联RS1990760 TRA1990760型糖尿病1型糖尿病的多态性和季节变异
机译:抗原特异性微粒系统可改善1型糖尿病和多发性硬化症小鼠模型的自身免疫
机译:选定的遗传多态性在糖尿病肾脏发生中的意义 - 糖尿病患者患者2 =糖尿病肾脏疾病中选定基因多态性的卷和2型糖尿病患者
机译:干扰素诱导解旋酶(IFIH1)基因多态性与从自身免疫到1型糖尿病的不同进展相关。
机译:干扰素诱导解旋酶(IFIH1)基因多态性与从自身免疫到1型糖尿病的不同进展相关。